missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. MA551874

Invitrogen™ Zalutumumab Recombinant Human Monoclonal Antibody (2F8 (Zalutumumab; HuMax-EGFR))
GREENER_CHOICE

Catalog No. MA551874
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MA551874 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MA551874 Supplier Invitrogen™ Supplier No. MA551874
Only null left

Description

Human Recombinant Monoclonal Antibody

This antibody binds domain III of the human epidermal growth factor receptor (EGFR).

Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

Specifications

Antigen Zalutumumab
Applications ELISA, Flow Cytometry, Western Blot
Classification Recombinant Monoclonal
Clone 2F8 (Zalutumumab; HuMax-EGFR)
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.02% ProClin 300
Gene Alias HuMax-EGFr
Host Species Human
Immunogen The original monoclonal antibody was generated by immunizing HuMAb mice with alternating A431 cells and purified EGFR administration.
Purification Method Protein A
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 κ
Show More Show Less